Sign in to continue:

Thursday, March 5th, 2026

China Innovation Investment Limited Expects 1,040% Net Profit Surge in 2025 Driven by Hong Kong Stock Market Gains 1





China Innovation Investment Limited: Positive Profit Alert

China Innovation Investment Limited Issues Significant Positive Profit Alert for FY2025

Key Highlights from the Announcement

  • Stellar Profit Growth: China Innovation Investment Limited has issued a profit alert, projecting a net profit of approximately HK\$57 million for the year ended 31 December 2025. This represents a dramatic year-on-year increase of about 1,040% compared to the net profit of approximately HK\$5 million reported for 2024.
  • Primary Growth Driver: The significant surge in profit is attributed mainly to a substantial increase in net investment gain, thanks to a strong return from the Hong Kong stock market during 2025.
  • Preliminary Figures: The announced figures are based on the Company’s preliminary unaudited management accounts and information currently available to the Board. The results have not yet been audited or reviewed by the audit committee and may be subject to further adjustments.

Important Information for Shareholders and Investors

  • Potential Share Price Impact: The announcement of a more than tenfold increase in net profit is highly price sensitive and may significantly affect the Company’s share value, given the magnitude of the improvement and its implications for the Company’s growth prospects and investment performance.
  • Upcoming Results Announcement: The final audited results for FY2025 are expected to be published on 24 March 2026. Investors should closely monitor this date for confirmation of the preliminary numbers and any additional disclosures.
  • Exercise Caution: The Board advises all shareholders and potential investors to exercise caution when dealing in the Company’s shares, as the results are still subject to possible changes before being finalized.

Details of the Board and Corporate Governance

  • Leadership Team: The Company is led by Mr. Xiang Xin, serving as Chairman and Chief Executive Officer. Other executive directors include Mr. Chan Cheong Yee. The independent non-executive directors are Ms. An Jing, Ms. Zhou Zan, and Ms. Qin Han, with Ms. Kung Ching acting as an alternate Director to Mr. Xiang Xin.

Summary

This positive profit alert from China Innovation Investment Limited signals a remarkable turnaround and growth in the Company’s profitability, primarily driven by robust investment returns in the Hong Kong stock market. The scale of the profit increase is likely to attract significant market attention and could have a notable impact on the Company’s share price. Nevertheless, investors are urged to exercise caution until the final audited results are released in late March 2026.


Disclaimer: This article is based on preliminary and unaudited figures released by China Innovation Investment Limited and is intended for informational purposes only. Investors should not rely solely on this information for investment decisions and are advised to review the Company’s final audited results and consult with financial advisors as appropriate. The final results may differ from the figures provided in this announcement.




View CH INNOVATION Historical chart here



Jiangsu Guofu Hydrogen Wins 80K Cold Box Project for National Fusion Research Platform, Expanding Cryogenic Engineering Capabilities

Jiangsu Guofu Hydrogen Energy Equipment Co., Ltd. Wins Major Cryogenic Systems Project Jiangsu Guofu Hydrogen Energy Equipment Co., Ltd. Announces Major Win in National Fusion Research Project Key Highlights Successful Bid for National Project:...

Zhejiang Tengy Environmental Technology Co., Ltd Announces Board Meeting to Approve 2025 Annual Results and Consider Final Dividends

Zhejiang Tengy Environmental Technology Co., Ltd – Board Meeting Announcement Zhejiang Tengy Environmental Technology Co., Ltd Announces Upcoming Board Meeting Key Highlights for Investors Board Meeting Scheduled: The Board of Directors of Zhejiang Tengy...

VISEN Pharmaceuticals Board Meeting Scheduled for March 12, 2026 to Approve 2025 Annual Results 1

Key Highlights for Investors Board Meeting Date: The board will meet on 12 March 2026. The timing of this meeting is important as it signals when shareholders and the market can expect the release...

   Ad